Design of VA CoronavirUs Research and Efficacy Studies-1 (VA CURES-1): A double-blind, randomized placebo-controlled trial of COVID-19 convalescent plasma in hospitalized patients with early respiratory compromise

Janoff, Edward N.; Brown, Sheldon T.; Belitskaya-Levy, Ilana; Curtis, Jeffrey L.; Bonomo, Robert A.; Miller, Elliott K.; Goldberg, Alexa M.; Zehm, Lisa; Wills, Ashlea; Hutchinson, Caitlin; Dumont, Larry J.; Gleason, Theresa; Shih, Mei-Chiung

doi:10.1016/j.conctc.2023.101190

Title: Design of VA CoronavirUs Research and Efficacy Studies-1 (VA CURES-1): A double-blind, randomized placebo-controlled trial of COVID-19 convalescent plasma in hospitalized patients with early respiratory compromise

Journal Article · 30 September 2023 · Contemporary Clinical Trials Communications

DOI: https://doi.org/10.1016/j.conctc.2023.101190 · OSTI ID:1992171

;

; Belitskaya-Levy, Ilana; Curtis, Jeffrey L.; Bonomo, Robert A.; Miller, Elliott K.; Goldberg, Alexa M.;

; Wills, Ashlea; Hutchinson, Caitlin;

; Gleason, Theresa; Shih, Mei-Chiung

Not Available

View Journal Article

Cite

Export

Save

Sponsoring Organization:: USDOE Office of Electricity (OE), Advanced Grid Research & Development. Power Systems Engineering Research

OSTI ID:: 1992171

Journal Information:: Contemporary Clinical Trials Communications, Journal Name: Contemporary Clinical Trials Communications Journal Issue: C Vol. 35; ISSN 2451-8654

Publisher:: ElsevierCopyright Statement

Country of Publication:: Country unknown/Code not available

Language:: English

References (48)

COVID-19 Convalescent Plasma Is More than Neutralizing Antibodies: A Narrative Review of Potential Beneficial and Detrimental Co-Factors Focosi, Daniele; Franchini, Massimo; Pirofski, Liise-anne Viruses, Vol. 13, Issue 8 https://doi.org/10.3390/v13081594	journal	August 2021
Effectiveness of convalescent plasma therapy in severe COVID-19 patients Duan, Kai; Liu, Bende; Li, Cesheng Proceedings of the National Academy of Sciences, Vol. 117, Issue 17 https://doi.org/10.1073/pnas.2004168117	journal	April 2020
The Effect of Convalescent Plasma Therapy on Mortality Among Patients With COVID-19: Systematic Review and Meta-analysis Klassen, Stephen A.; Senefeld, Jonathon W.; Johnson, Patrick W. Mayo Clinic Proceedings, Vol. 96, Issue 5 https://doi.org/10.1016/j.mayocp.2021.02.008	journal	May 2021
Treatment With Convalescent Plasma for Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection Zhang, Bin; Liu, Shuyi; Tan, Tan Chest, Vol. 158, Issue 1 https://doi.org/10.1016/j.chest.2020.03.039	journal	July 2020
Treatment of Coronavirus Disease 2019 (COVID-19) Patients with Convalescent Plasma Salazar, Eric; Perez, Katherine K.; Ashraf, Madiha The American Journal of Pathology, Vol. 190, Issue 8 https://doi.org/10.1016/j.ajpath.2020.05.014	journal	August 2020
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis Sterne, Jonathan A. C.; Murthy, Srinivas; Diaz, Janet V. JAMA, Vol. 324, Issue 13 https://doi.org/10.1001/jama.2020.17023	journal	October 2020
Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults Libster, Romina; Pérez Marc, Gonzalo; Wappner, Diego New England Journal of Medicine, Vol. 384, Issue 7 https://doi.org/10.1056/NEJMoa2033700	journal	February 2021
Hyperimmune IV Immunoglobulin Treatment Hung, Ivan F. N.; To, Kelvin K. W.; Lee, Cheuk-Kwong Chest, Vol. 144, Issue 2 https://doi.org/10.1378/chest.12-2907	journal	August 2013
Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020 Chow, Nancy; Fleming-Dutra, Katherine; Gierke, Ryan MMWR. Morbidity and Mortality Weekly Report, Vol. 69, Issue 13 https://doi.org/10.15585/mmwr.mm6913e2	journal	April 2020
Effect of Convalescent Plasma on Organ Support–Free Days in Critically Ill Patients With COVID-19 JAMA, Vol. 326, Issue 17 https://doi.org/10.1001/jama.2021.18178	journal	November 2021
Early Outpatient Treatment for Covid-19 with Convalescent Plasma Sullivan, David J.; Gebo, Kelly A.; Shoham, Shmuel New England Journal of Medicine, Vol. 386, Issue 18 https://doi.org/10.1056/NEJMoa2119657	journal	May 2022
Functional convalescent plasma antibodies and pre-infusion titers shape the early severe COVID-19 immune response Herman, Jonathan D.; Wang, Chuangqi; Loos, Carolin Nature Communications, Vol. 12, Issue 1 https://doi.org/10.1038/s41467-021-27201-y	journal	November 2021
Association of Convalescent Plasma Treatment With Clinical Status in Patients Hospitalized With COVID-19 Troxel, Andrea B.; Petkova, Eva; Goldfeld, Keith JAMA Network Open, Vol. 5, Issue 1 https://doi.org/10.1001/jamanetworkopen.2021.47331	journal	January 2022
High-Throughput Neutralization and Serology Assays Reveal Correlated but Highly Variable Humoral Immune Responses in a Large Population of Individuals Infected with SARS-CoV-2 in the US between March and August 2020 Zhang, Shuting; Ma, Peijun; Orzechowski, Marek mBio, Vol. 14, Issue 2 https://doi.org/10.1128/mbio.03523-22	journal	April 2023
Designing and implementing methodology for double-blind, placebo-controlled clinical trials using blood products within the Department of Veterans Affairs Miller, Elliott K.; Goldberg, Alexa M.; Janoff, Edward N. Clinical Trials, Vol. 19, Issue 2 https://doi.org/10.1177/17407745211069703	journal	March 2022
The Urgency of Care during the Covid-19 Pandemic — Learning as We Go Rubin, Eric J.; Harrington, David P.; Hogan, Joseph W. New England Journal of Medicine, Vol. 382, Issue 25 https://doi.org/10.1056/NEJMe2015903	journal	June 2020
Associations Between Symptoms, Donor Characteristics and IgG Antibody Response in 2082 COVID-19 Convalescent Plasma Donors Vinkenoog, Marieke; Steenhuis, Maurice; Brinke, Anja ten Frontiers in Immunology, Vol. 13 https://doi.org/10.3389/fimmu.2022.821721	journal	February 2022
Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials Ferreira-González, Ignacio; Permanyer-Miralda, Gaiet; Domingo-Salvany, Antònia BMJ, Vol. 334, Issue 7597 https://doi.org/10.1136/bmj.39136.682083.AE	journal	April 2007
Treatment with convalescent plasma for COVID‐19 patients in Wuhan, China Ye, Mingxiang; Fu, Dian; Ren, Yi Journal of Medical Virology, Vol. 92, Issue 10 https://doi.org/10.1002/jmv.25882	journal	June 2020
Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial Marconi, Vincent C.; Ramanan, Athimalaipet V.; de Bono, Stephanie The Lancet Respiratory Medicine, Vol. 9, Issue 12 https://doi.org/10.1016/S2213-2600(21)00331-3	journal	December 2021
Comparative Effectiveness of BNT162b2 and mRNA-1273 Vaccines in U.S. Veterans Dickerman, Barbra A.; Gerlovin, Hanna; Madenci, Arin L. New England Journal of Medicine, Vol. 386, Issue 2 https://doi.org/10.1056/NEJMoa2115463	journal	January 2022
COVID‐19 convalescent plasma: Interim recommendations from theAABB Cohn, Claudia S.; Estcourt, Lise; Grossman, Brenda J. Transfusion, Vol. 61, Issue 4 https://doi.org/10.1111/trf.16328	journal	March 2021
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19 Cao, Bin; Wang, Yeming; Wen, Danning New England Journal of Medicine, Vol. 382, Issue 19 https://doi.org/10.1056/NEJMoa2001282	journal	May 2020
Use of convalescent plasma therapy in SARS patients in Hong Kong Cheng, Y.; Wong, R.; Soo, Y. O. Y. European Journal of Clinical Microbiology & Infectious Diseases, Vol. 24, Issue 1 https://doi.org/10.1007/s10096-004-1271-9	journal	December 2004
Passive Immunity Trial for Our Nation (PassITON): study protocol for a randomized placebo-control clinical trial evaluating COVID-19 convalescent plasma in hospitalized adults Self, Wesley H.; Stewart, Thomas G. Trials, Vol. 22, Issue 1 https://doi.org/10.1186/s13063-021-05171-2	journal	March 2021
Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options McCreary, Erin K.; Pogue, Jason M. Open Forum Infectious Diseases, Vol. 7, Issue 4 https://doi.org/10.1093/ofid/ofaa105	journal	March 2020
Convalescent plasma treatment of severe COVID-19: a propensity score–matched control study Liu, Sean T. H.; Lin, Hung-Mo; Baine, Ian Nature Medicine, Vol. 26, Issue 11 https://doi.org/10.1038/s41591-020-1088-9	journal	September 2020
High-titre methylene blue-treated convalescent plasma as an early treatment for outpatients with COVID-19: a randomised, placebo-controlled trial Alemany, Andrea; Millat-Martinez, Pere; Corbacho-Monné, Marc The Lancet Respiratory Medicine, Vol. 10, Issue 3 https://doi.org/10.1016/S2213-2600(21)00545-2	journal	March 2022
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma Shen, Chenguang; Wang, Zhaoqin; Zhao, Fang JAMA, Vol. 323, Issue 16 https://doi.org/10.1001/jama.2020.4783	journal	April 2020
Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial) Agarwal, Anup; Mukherjee, Aparna; Kumar, Gunjan BMJ https://doi.org/10.1136/bmj.m3939	journal	October 2020
The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis Mair-Jenkins, John; Saavedra-Campos, Maria; Baillie, J. Kenneth Journal of Infectious Diseases, Vol. 211, Issue 1 https://doi.org/10.1093/infdis/jiu396	journal	July 2014
Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19 Geleris, Joshua; Sun, Yifei; Platt, Jonathan New England Journal of Medicine, Vol. 382, Issue 25 https://doi.org/10.1056/NEJMoa2012410	journal	June 2020
Effect of Convalescent Plasma Therapy on Viral Shedding and Survival in Patients With Coronavirus Disease 2019 Zeng, Qing-Lei; Yu, Zu-Jiang; Gou, Jian-Jun The Journal of Infectious Diseases, Vol. 222, Issue 1 https://doi.org/10.1093/infdis/jiaa228	journal	April 2020
The evolution of SARS-CoV-2 Markov, Peter V.; Ghafari, Mahan; Beer, Martin Nature Reviews Microbiology, Vol. 21, Issue 6 https://doi.org/10.1038/s41579-023-00878-2	journal	April 2023
Anti-influenza immune plasma for the treatment of patients with severe influenza A: a randomised, double-blind, phase 3 trial Beigel, John H.; Aga, Evgenia; Elie-Turenne, Marie-Carmelle The Lancet Respiratory Medicine, Vol. 7, Issue 11 https://doi.org/10.1016/S2213-2600(19)30199-7	journal	November 2019
REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19 Weinreich, David M.; Sivapalasingam, Sumathi; Norton, Thomas New England Journal of Medicine, Vol. 385, Issue 23 https://doi.org/10.1056/NEJMoa2108163	journal	December 2021
Efficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients Ortigoza, Mila B.; Yoon, Hyunah; Goldfeld, Keith S. JAMA Internal Medicine, Vol. 182, Issue 2 https://doi.org/10.1001/jamainternmed.2021.6850	journal	February 2022
Mortality in individuals treated with COVID-19 convalescent plasma varies with the geographic provenance of donors Kunze, Katie L.; Johnson, Patrick W.; van Helmond, Noud Nature Communications, Vol. 12, Issue 1 https://doi.org/10.1038/s41467-021-25113-5	journal	August 2021
Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial Li, Ling; Zhang, Wei; Hu, Yu JAMA, Vol. 324, Issue 5 https://doi.org/10.1001/jama.2020.10044	journal	August 2020
Early Convalescent Plasma for High-Risk Outpatients with Covid-19 Korley, Frederick K.; Durkalski-Mauldin, Valerie; Yeatts, Sharon D. New England Journal of Medicine, Vol. 385, Issue 21 https://doi.org/10.1056/NEJMoa2103784	journal	November 2021
A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia Simonovich, Ventura A.; Burgos Pratx, Leandro D.; Scibona, Paula New England Journal of Medicine, Vol. 384, Issue 7 https://doi.org/10.1056/NEJMoa2031304	journal	February 2021
Factors That Influence the Immune Response to Vaccination Zimmermann, Petra; Curtis, Nigel Clinical Microbiology Reviews, Vol. 32, Issue 2 https://doi.org/10.1128/CMR.00084-18	journal	March 2019
Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study Beigel, John H.; Tebas, Pablo; Elie-Turenne, Marie-Carmelle The Lancet Respiratory Medicine, Vol. 5, Issue 6 https://doi.org/10.1016/S2213-2600(17)30174-1	journal	June 2017
Clinical Characteristics of Coronavirus Disease 2019 in China Guan, Wei-jie; Ni, Zheng-yi; Hu, Yu New England Journal of Medicine, Vol. 382, Issue 18 https://doi.org/10.1056/NEJMoa2002032	journal	April 2020
Remdesivir for the Treatment of Covid-19 — Final Report Beigel, John H.; Tomashek, Kay M.; Dodd, Lori E. New England Journal of Medicine, Vol. 383, Issue 19 https://doi.org/10.1056/NEJMoa2007764	journal	November 2020
Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea van Griensven, Johan; Edwards, Tansy; de Lamballerie, Xavier New England Journal of Medicine, Vol. 374, Issue 1 https://doi.org/10.1056/NEJMoa1511812	journal	January 2016
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19 Joyner, Michael J.; Carter, Rickey E.; Senefeld, Jonathon W. New England Journal of Medicine, Vol. 384, Issue 11 https://doi.org/10.1056/NEJMoa2031893	journal	March 2021
Treatment of Ebola Hemorrhagic Fever with Blood Transfusions from Convalescent Patients Mupapa, K.; Massamba, M.; Kibadi, K. The Journal of Infectious Diseases, Vol. 179, Issue s1 https://doi.org/10.1086/514298	journal	February 1999

Similar Records

Yokukansan for Treatment of Preoperative Anxiety and Prevention of Postoperative Delirium in Cancer Patients Undergoing Highly Invasive Surgery. J-SUPPORT 1605 (ProD Study): A Randomized, Double-Blind, Placebo-Controlled Trial

Journal Article · 2020 · Journal of Pain and Symptom Management · OSTI ID:2274711

Wada, Saho; Sadahiro, Ryoichi; Matsuoka, Yutaka J.; +11 more

A double-blind placebo-controlled randomized phase II trial assessing the activity and safety of regorafenib in non-adipocytic sarcoma patients previously treated with both chemotherapy and pazopanib

Journal Article · 2020 · European Journal of Cancer (1990) · OSTI ID:1778496

Penel, Nicolas; Mir, Olivier; Wallet, Jennifer; +17 more

Prevention of acute radiation-induced proctosigmoiditis by balsalazide: A randomized, double-blind, placebo controlled trial in prostate cancer patients

Journal Article · 2005 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:20788243

Jahraus, Christopher D; Bettenhausen, Doug Phar; Sellitti, Marguerite; +1 more

Title: Design of VA CoronavirUs Research and Efficacy Studies-1 (VA CURES-1): A double-blind, randomized placebo-controlled trial of COVID-19 convalescent plasma in hospitalized patients with early respiratory compromise

Citation Formats

References (48)

Similar Records

Related Subjects